Cargando…
传统免疫化疗时代118例TP53基因异常慢性淋巴细胞白血病患者生存分析
OBJECTIVE: To analyze the survival and first-line immune-chemotherapy (CIT) of chronic lymphocytic leukemia (CLL) with abnormal TP53 gene in the era of traditional CIT. METHODS: The clinical data of 118 CLL patients diagnosed from January 2003 to August 2017 were collected. Survival was analyzed acc...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342240/ https://www.ncbi.nlm.nih.gov/pubmed/31207701 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.006 |